AGIO AGIOS PHARMACEUTICALS, INC.
Price Chart
Executive Summary
Two insiders at Agios Pharmaceuticals sold shares in the past week, including the Chief Corporate Development & Strategy Officer and the Principal Accounting Officer, realizing $234,515 in open-market sales. The transactions were accompanied by non-cash derivative exercises. Total sales represent a negligible fraction of the company's $1.6B market cap.
Key Financial Metrics
Actionable Insight
The level of selling is routine and not economically significant relative to company size; no immediate trading signal. Monitor for escalation in volume or broader insider participation.
Key Facts
- Viswanadhan Krishnan (Chief Corp Dev & Strategy) sold 2,959 shares for $82,260 and exercised derivatives for 16,200 shares (non-cash, $0 value).
- Theodore James Washburn (Principal Accounting Officer) sold 5,272 shares for $152,255.
- Total open-market sales: $234,515 across two insiders in the last 7 days.
- Sales represent only 0.015% of Agios's $1.6B market capitalization.
- No purchases or other cash-in transactions observed in the cluster.
Financial Impact
$234,515 in net insider selling over 7 days
Risk Factors
- Perception risk if additional insiders sell in coming weeks.
- Non-cash derivative exercises may lead to future selling pressure if shares are used to cover taxes or diversify holdings.
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-AGIO-1773087170152 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
Press Release
| $28.00 $28.29 | ▲ +1.04% | ▲ +3.79% | $27.44 (−2.00%) |
|
May 29, 2026
11d ago
|
Press Release
| $29.40 $27.68 | ▲ +5.85% | ▲ +5.56% | $27.44 (+6.67%) |
|
Apr 29, 2026
5w ago
|
8-K
| $28.05 $26.98 | ▼ −3.81% | ▼ −6.92% | $27.44 (−2.17%) |
|
Apr 29, 2026
5w ago
|
Press Release
| $28.05 $26.98 | ▼ −3.81% | ▼ −6.92% | $27.44 (−2.17%) |
|
Apr 24, 2026
6w ago
|
DEFA14A
| $24.43 $27.56 | ▲ +12.81% | ▲ +12.41% | $27.44 (+12.32%) |
|
Apr 6, 2026
9w ago
|
Press Release
| $34.80 $33.15 | ▼ −4.74% | ▼ −8.88% | $27.44 (−21.15%) |
|
Mar 3, 2026
14w ago
|
Insider Cluster
| $28.48 $28.26 | ▼ −0.77% | ▼ −0.29% | $27.44 (−3.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access